Bristol Myers Boosts 2026 Outlook After Earnings Beat: What Investors Need to Know | MarketWire
Bristol Myers Squibb surged Thursday as strong Q4 earnings and an optimistic 2026 outlook lifted investor confidence. Here's how the pharmaceutical giant is positioning for growth.